Northeast Pharmaceutical Group Co., Ltd. (SHE:000597)
China · Delayed Price · Currency is CNY 4.610
+0.040 (0.88%)
Jul 29, 2026, 3:04 PM CST
SHE:000597 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 3,750 | 3,602 | 4,468 | 5,651 | 3,845 | 2,550 |
Trading Asset Securities | 219.64 | 0.35 | - | - | - | - |
Cash & Short-Term Investments | 3,970 | 3,602 | 4,468 | 5,651 | 3,845 | 2,550 |
Cash Growth | 17.25% | -19.39% | -20.93% | 46.98% | 50.76% | 72.18% |
Accounts Receivable | 2,805 | 2,423 | 2,494 | 2,404 | 2,539 | 2,376 |
Other Receivables | 198.37 | 186.39 | 192.51 | 191.25 | 195.93 | 392.21 |
Receivables | 3,003 | 2,610 | 2,687 | 2,596 | 2,735 | 2,768 |
Inventory | 1,234 | 1,182 | 1,324 | 1,364 | 1,220 | 1,247 |
Prepaid Expenses | - | 2.2 | 0.63 | 1.17 | 2.86 | 16.64 |
Other Current Assets | 133.38 | 136.62 | 166.73 | 171.05 | 127.39 | 216.56 |
Total Current Assets | 8,340 | 7,532 | 8,646 | 9,783 | 7,931 | 6,799 |
Property, Plant & Equipment | 3,523 | 3,630 | 4,064 | 4,477 | 4,852 | 5,226 |
Long-Term Investments | 4.73 | 4.73 | 6.13 | - | - | - |
Goodwill | 153.26 | 153.4 | 154.45 | 26.12 | 26.12 | 26.12 |
Other Intangible Assets | 647.65 | 661.23 | 687.83 | 681.77 | 706.96 | 651.76 |
Long-Term Deferred Tax Assets | 142.87 | 137.64 | 131.38 | 128.07 | 109.29 | 102.09 |
Long-Term Deferred Charges | 770.57 | 762.72 | 742.05 | 143.47 | 122.36 | 302.5 |
Other Long-Term Assets | 7.69 | 6.65 | 13.97 | 34.47 | 62.66 | 71.34 |
Total Assets | 13,590 | 12,889 | 14,446 | 15,274 | 13,810 | 13,180 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Accounts Payable | 3,703 | 2,862 | 4,841 | 5,778 | 4,320 | 3,696 |
Accrued Expenses | 8.28 | 872.21 | 853.78 | 744.07 | 701.69 | 561.28 |
Short-Term Debt | 1,670 | 1,892 | 1,542 | 1,290 | 1,882 | 2,050 |
Current Portion of Long-Term Debt | - | 23.6 | - | 688 | 42 | 200 |
Current Portion of Leases | - | 21.79 | 20.23 | 23.52 | 17.58 | 20.21 |
Current Income Taxes Payable | 72.09 | 22.69 | 46.22 | 55.58 | 104.58 | 28.27 |
Current Unearned Revenue | 75.46 | 87.9 | 104.81 | 131.17 | 192.72 | 127.78 |
Other Current Liabilities | 1,725 | 781.39 | 849.18 | 858.07 | 1,162 | 1,515 |
Total Current Liabilities | 7,253 | 6,564 | 8,257 | 9,568 | 8,423 | 8,199 |
Long-Term Debt | 154.6 | 154.6 | - | 150 | 238 | 200 |
Long-Term Leases | 19.42 | 19.82 | 30.14 | 31.29 | 17.94 | 17.97 |
Long-Term Unearned Revenue | 121.88 | 126.2 | 140.91 | 157.12 | 174.72 | 194.05 |
Long-Term Deferred Tax Liabilities | 93.78 | 93.73 | 95.74 | 5.22 | 5.32 | 5.42 |
Other Long-Term Liabilities | 262.36 | 261.56 | 352.83 | 202.8 | 238 | 273.2 |
Total Liabilities | 7,905 | 7,220 | 8,877 | 10,115 | 9,097 | 8,889 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Common Stock | 1,427 | 1,427 | 1,429 | 1,429 | 1,434 | 1,348 |
Additional Paid-In Capital | 2,519 | 2,519 | 2,490 | 2,468 | 2,375 | 2,146 |
Retained Earnings | 1,605 | 1,578 | 1,461 | 1,194 | 978.13 | 646.81 |
Treasury Stock | -2.47 | -2.47 | -67.13 | -110.72 | -234.78 | - |
Comprehensive Income & Other | 7 | 7.84 | 8.97 | 8.41 | 7.17 | 2.65 |
Total Common Equity | 5,556 | 5,530 | 5,322 | 4,988 | 4,559 | 4,144 |
Minority Interest | 129.13 | 139.4 | 248.03 | 170.47 | 153.95 | 146.54 |
Shareholders' Equity | 5,685 | 5,669 | 5,570 | 5,159 | 4,713 | 4,290 |
Total Liabilities & Equity | 13,590 | 12,889 | 14,446 | 15,274 | 13,810 | 13,180 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Total Debt | 1,844 | 2,112 | 1,593 | 2,183 | 2,198 | 2,488 |
Net Cash (Debt) | 2,126 | 1,491 | 2,876 | 3,468 | 1,647 | 62.17 |
Net Cash Growth | 61.91% | -48.17% | -17.08% | 110.51% | 2549.68% | - |
Net Cash Per Share | 1.48 | 1.03 | 2.03 | 2.42 | 1.18 | 0.04 |
Filing Date Shares Outstanding | 1,427 | 1,427 | 1,429 | 1,429 | 1,434 | 1,348 |
Total Common Shares Outstanding | 1,427 | 1,427 | 1,429 | 1,429 | 1,434 | 1,348 |
Working Capital | 1,087 | 968.51 | 389.56 | 214.57 | -492.6 | -1,399 |
Book Value Per Share | 3.89 | 3.87 | 3.72 | 3.49 | 3.18 | 3.07 |
Tangible Book Value | 4,755 | 4,715 | 4,479 | 4,280 | 3,826 | 3,466 |
Tangible Book Value Per Share | 3.33 | 3.30 | 3.13 | 3.00 | 2.67 | 2.57 |
Buildings | - | 3,146 | 3,123 | 3,101 | 3,011 | 2,965 |
Machinery | - | 5,193 | 5,177 | 5,047 | 4,808 | 4,606 |
Construction In Progress | - | 99.11 | 155.48 | 198.87 | 421.64 | 678.41 |